Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Active not recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 5Uterine Cervical Neoplasms 2Sarcoma 2Oropharyngeal Neoplasms 2Lung Neoplasms 2Hodgkin Disease 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Rhabdoid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, Mantle-Cell 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Plasma Cell 1HIV Infections 1Disease 1Chordoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 13Magnetic Resonance Spectroscopy 9Specimen Handling 8Radiotherapy 7Platinum 71,2-diaminocyclohexaneplatinum II citrate 7Radiotherapy, Intensity-Modulated 4Radiation 4Biopsy 4Surveys and Questionnaires 3Nivolumab 3Carboplatin 3pembrolizumab 2durvalumab 2Observation 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Docetaxel 2Disulfides 2Chemoradiotherapy 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2niraparib 1merphos 1ipatasertib 1dostarlimab 1cemiplimab 1cabozantinib 1balstilimab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Fluorodeoxyglucose F18 × 30 days × Clear all
NCT03952585 2026-06-01

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

NCT03811015 2026-05-29

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
636 enrolled
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡